KATZMANN LYNNE S 4

What Happened

• Lynne S. Katzmann, a director of Sabra Health Care REIT (SBRA), was credited with 781 stock units on 2026-02-27 as an award/acquisition (reported at $0.00 per unit, total reported value $0). The filing lists these as dividend-equivalent stock units tied to previously granted stock units.

Key Details

• Transaction date: 2026-02-27; Form 4 filed: 2026-03-03 (filed within the normal 2-business-day window for Form 4s).
• Transaction type/code: A (award/grant/acquisition); reported price: $0.00; units received: 781.
• Post-transaction holdings (per filing footnote): includes 2,854 unvested stock units and 51,345 vested stock units for which payment has been deferred. Each stock unit equals the right to receive one share.
• Footnote F1: the 781 units are dividend-equivalent payments on outstanding stock units and will vest/pay under the same terms as the original awards.
• No 10b5-1 plan, tax-withholding sale, or late-filing flag was noted in the filing.

Context

• These are dividend-equivalent stock units tied to existing awards, not an open-market purchase or sale. Such grants increase future equity exposure if/when they vest or are paid but do not reflect an immediate cash investment by the insider. For retail investors, awards like this are routine compensation-related events rather than a direct signal of near-term insider buying or selling.